title: Chronic myeloid leukemia in a patient with chronic idiopathic thrombocytopenic purpura: rapid response to imatinib mesylate (STI571).
authors.affiliation: Kyoto City Institute of Health and Environmental Sciences, Kyoto Prefectural University of Medicine, Kyoto, Japan. shinim95@mbox.kyoto-inet.or.jp
authors.forename: Shinsaku
authors.initials: S
authors.lastname: Imashuku
authors.forename: Akira
authors.initials: A
authors.lastname: Morimoto
authors.forename: Kikuko
authors.initials: K
authors.lastname: Kuriyama
authors.forename: Gen
authors.initials: G
authors.lastname: Kano
authors.forename: Shigeyoshi
authors.initials: S
authors.lastname: Hibi
authors.forename: Shinjiro
authors.initials: S
authors.lastname: Todo
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides; D002648:Child; D002675:Child, Preschool; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000209:etiology*; D008297:Male; D010879:Piperazines / Q000627:therapeutic use*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors / Q000627:therapeutic use*; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000150:complications*; D011743:Pyrimidines / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate; D011505:Protein-Tyrosine Kinases